Provide strategy update for KB301 and aesthetic pipeline
Delivered by the deadline
AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.
- Announced
- 7 Jan 2021
- Due
- 31 Mar 2021
- Delivered
- 24 Mar 2021
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“1Q21 KB301 for aesthetic indications Provide update on strategy for KB301 and aesthetic pipeline (under Jeune Inc.)”
What we found
Evidence strength A What the grades mean
The company provided an update on the KB301 aesthetic pipeline and strategy on March 24, 2021, by announcing initial Phase 1 study data and confirming the ongoing development status of the program.
-
A Krystal Biotech, Inc. 10-Q filed 2021-05-10
“On March 24, 2021 we announced initial data from Cohort 1 of the Phase 1 study that showed safety and tolerability of two (2) repeat KB301 injections in human subjects.” ✓ confirmed on the page
Market reaction: the shares moved -7.4% against the S&P 500 over the three sessions around the disclosure (7 May 2021 to 12 May 2021). What this measures
Checked 24 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Project other
- Indicative materiality
- Low rules
- Action
- Provide
- Deliverable
- KB301 and aesthetic pipeline strategy update
- In the company’s control
- High
- Specificity
- High
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: disagreesClaude (Anthropic) re-read the evidence blind and read it as “Late”.
- Tie-breakA stronger model read the evidence and both earlier answers, without knowing which was recorded, and agrees with the recorded outcome.
Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works
Are you Krystal Biotech, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-KRYS-021264 · Corrections policy